Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8212823rdf:typepubmed:Citationlld:pubmed
pubmed-article:8212823lifeskim:mentionsumls-concept:C0019163lld:lifeskim
pubmed-article:8212823lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:8212823lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:8212823lifeskim:mentionsumls-concept:C1519885lld:lifeskim
pubmed-article:8212823pubmed:issue10lld:pubmed
pubmed-article:8212823pubmed:dateCreated1993-10-29lld:pubmed
pubmed-article:8212823pubmed:abstractTextOf 79 children born to asymptomatic HBsAg chronic carrier mothers and vaccinated at birth against hepatitis B, a total of 71, 66 and 56 could be serologically assessed after 1, 5 and 7 years, respectively. Anti-HBs titres (geometric means) of responders decreased from 2475 to 143 IU l-1 between 1 and 5 years of age and dropped to 82 IU l-1 by 7 years. At this time, a booster dose given to 34 children who showed anti-HBs titres lower or slightly higher than 100 IU l-1 significantly increased titres from 34 to 2985 IU l-1 (p < 0.001). Children whose titres following perinatal vaccination reached 100 to 1000 IU l-1 or above 1000 IU l-1 maintained protective levels (> 10 IU l-1) for 3 and 5 years, respectively. As in adults, anti-HBs titres recorded after the initial vaccination indicate the time at which infants should receive booster vaccination.lld:pubmed
pubmed-article:8212823pubmed:languageenglld:pubmed
pubmed-article:8212823pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8212823pubmed:citationSubsetIMlld:pubmed
pubmed-article:8212823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8212823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8212823pubmed:statusMEDLINElld:pubmed
pubmed-article:8212823pubmed:issn0264-410Xlld:pubmed
pubmed-article:8212823pubmed:authorpubmed-author:GonzalezJ BJBlld:pubmed
pubmed-article:8212823pubmed:authorpubmed-author:GonzalezM LMLlld:pubmed
pubmed-article:8212823pubmed:authorpubmed-author:LardinoisRRlld:pubmed
pubmed-article:8212823pubmed:authorpubmed-author:TABINJ KJKlld:pubmed
pubmed-article:8212823pubmed:issnTypePrintlld:pubmed
pubmed-article:8212823pubmed:volume11lld:pubmed
pubmed-article:8212823pubmed:ownerNLMlld:pubmed
pubmed-article:8212823pubmed:authorsCompleteYlld:pubmed
pubmed-article:8212823pubmed:pagination1033-6lld:pubmed
pubmed-article:8212823pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:meshHeadingpubmed-meshheading:8212823-...lld:pubmed
pubmed-article:8212823pubmed:year1993lld:pubmed
pubmed-article:8212823pubmed:articleTitleA 7-year follow-up of newborns vaccinated against hepatitis B.lld:pubmed
pubmed-article:8212823pubmed:affiliationDepartment of Gynecology and Obstetrics, Hospital Son Dureta, Palma de Mallorca, Spain.lld:pubmed
pubmed-article:8212823pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8212823pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8212823pubmed:publicationTypeControlled Clinical Triallld:pubmed